Document Detail


The relationship between wheezing and lung mechanics during methacholine-induced bronchoconstriction in asthmatic subjects.
MedLine Citation:
PMID:  8756796     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Wheeze is a classic sign of airflow obstruction but relatively little is known of its mechanism of production or its relationship to the development of airflow obstruction. We studied eight asthmatic subjects age (mean +/- 5D) 42 +/- 5 yr, FEV1 2.46 +/- 0.36 L during an extended, symptom-limited methacholine challenge test. Breath sounds were detected by a microphone over the right upper anterior chest. Spectral analysis was by a fast Fourier transform algorithm. Mean FEV1 fell by 51 +/- 14% to 1.28 +/- 0.61 L during the challenge and airways resistance increased by 119 +/- 50%. There were no consistent changes in breathing pattern or tidal volume during the challenge. Wheeze occurred late in the challenge at the highest concentration of methacholine administered and only after expiratory tidal flow limitation had been reached. Five subjects developed wheeze on tidal breathing, the remaining three only wheezed on deep breathing. Wheezing sounds were reproducible between breaths, coefficient of variation of starting sound frequency was 4.2% and ending frequency 12%. Mean frequency of expiratory wheezes was 669 +/- 100 Hz and inspiratory wheezes 710 +/- 76 Hz. Expiratory wheeze fell in pitch during a breath (mean fall in sound frequency 187 +/- 43 Hz) but inspiratory wheezes were more variable. Expiratory wheezes occurred late in the respiratory cycle at a mean of 58% of the maximal tidal expiratory flow, whereas inspiratory wheezes occurred around maximal tidal inspiratory flows, suggesting that the mechanisms of production of inspiratory and expiratory wheezes may be different. In this model, the presence of wheeze during tidal breathing was a sign of severe airflow limitation.
Authors:
D P Spence; D R Graham; G Jamieson; B M Cheetham; P M Calverley; J E Earis
Related Documents :
15374766 - Influence of inspiratory resistance on performance during graded exercise tests on a cy...
11079516 - Expiratory flow limitation confounds ventilatory response during exercise in athletes.
2318766 - Inspiratory and expiratory muscle perfusion in maximally exercised ponies.
5033466 - The importance of timing on the respiratory effects of intermittent carotid body chemor...
1462906 - Irregular ventricular tachycardia: a possible manifestation of longitudinal dissociatio...
17280706 - Effect of clomazone herbicide on biochemical and histological aspects of silver catfish...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of respiratory and critical care medicine     Volume:  154     ISSN:  1073-449X     ISO Abbreviation:  Am. J. Respir. Crit. Care Med.     Publication Date:  1996 Aug 
Date Detail:
Created Date:  1996-10-24     Completed Date:  1996-10-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9421642     Medline TA:  Am J Respir Crit Care Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  290-4     Citation Subset:  AIM; IM    
Affiliation:
Aintree Chest Centre, Fazakerley Hospital, Liverpool, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Asthma / diagnosis,  physiopathology*
Bronchial Provocation Tests
Bronchoconstriction / physiology
Bronchoconstrictor Agents / diagnostic use
Fourier Analysis
Humans
Maximal Expiratory Flow-Volume Curves / physiology
Methacholine Chloride / diagnostic use
Pulmonary Ventilation / physiology
Respiratory Mechanics / physiology*
Respiratory Sounds / physiopathology*
Signal Processing, Computer-Assisted
Tidal Volume / physiology
Chemical
Reg. No./Substance:
0/Bronchoconstrictor Agents; 62-51-1/Methacholine Chloride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Glucocorticoid-resistant asthma. T-lymphocyte defects.
Next Document:  Inhaled misoprostol blocks guinea pig antigen-induced bronchoconstriction and airway inflammation.